This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Long-term health risks

Authoring team

Future risks if gestational hypertension

Future risks if preeclampsia

Future risks if severe preeclampsia, HELLP syndrome or eclampsia

Gestational hypertension in future pregnancy

Risk ranges from about 1 in 6 (16%) to about 1 in 2 (53%).

Risk ranges from about1 in 8 (13%) to about 1 in 2 (47%)

Preeclampsia in future pregnancy

Risk ranges from 1 in 50 (2%) to about 1 in 14 (7%)

Risk up to about 1 in 6 (16%). No additional risk if interval before next pregnancy < 10 years

 

If birth was needed before 34 weeks risk is about 1 in 4 (25%).

If birth was needed before 28 weeks risk is about 1 in 2 (55%).

Cardiovascular disease

Increased risk of hypertension and its complications

Increased risk of hypertension and its complications

Increased risk of hypertension and its complications

End-stage kidney disease

If no proteinuria and no hypertension at 6-8 week postnatal review, relative risk increased but absolute risk low. No follow-up needed.

Thrombophilia

Routine screening not needed

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.